REQUEST A DEMO
Total
USD $0.00
Search more companies

Martyn-Drog Sp. z o.o. (Poland)

Main Activities: Highway, Street, and Bridge Construction
Full name: Martyn-Drog Sp. z o.o. Profile Updated: April 17, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Polish Download a sample report

Martyn-Drog Sp. z o.o. is an enterprise based in Poland. Its main office is in Rzasiny. It operates in the Highway, Street, and Bridge Construction industry. The enterprise was incorporated on December 18, 2020. From the latest financial highlights, Martyn-Drog Sp. z o.o. reported a net sales revenue increase of 79.66% in 2025. A growth of 23.33% was recorded in its total assets. The net profit margin of Martyn-Drog Sp. z o.o. decreased by 26.75% in 2025.

Headquarters
Rzasiny 103
Rzasiny; Dolnoslaskie; Postal Code: 59-620

Contact Details: Purchase the Martyn-Drog Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Martyn-Drog Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Martyn-Drog Sp. z o.o. report to view the information.
Incorporation Date:
December 18, 2020
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
80%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Martyn-Drog Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
79.66%
Total Operating Revenue
80.46%
Operating Profit
-49.99%
EBITDA
-44.84%
Net Profit/Loss for the Period
-49.34%
Total Assets
23.33%
Total Equity
31.33%
Operating Profit Margin
-28.79%
Net Profit Margin
-26.75%
Return on Equity (ROE)
-45.67%
Quick Ratio
1.27%

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?